These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28067885)

  • 1. Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization.
    Grosso D; Johnson E; Colombe B; Alpdogan O; Carabasi M; Filicko-O'Hara J; Gaballa S; Kasner M; Klumpp T; Martinez-Outschoorn U; Wagner JL; Weiss M; Wang Z; Flomenberg N
    Bone Marrow Transplant; 2017 Apr; 52(4):615-619. PubMed ID: 28067885
    [No Abstract]   [Full Text] [Related]  

  • 2. Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
    Blaise D; Fürst S; Crocchiolo R; El-Cheikh J; Granata A; Harbi S; Bouabdallah R; Devillier R; Bramanti S; Lemarie C; Picard C; Chabannon C; Weiller PJ; Faucher C; Mohty B; Vey N; Castagna L
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):119-24. PubMed ID: 26341397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia.
    Fu H; Xu L; Liu D; Liu K; Zhang X; Chen H; Chen Y; Han W; Wang Y; Wang J; Wang F; Huang X
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1176-82. PubMed ID: 24747336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide.
    Castagna L; Bramanti S; Furst S; Giordano L; Sarina B; Crocchiolo R; El-Cheikh J; Granata A; Morabito L; Mauro E; Faucher C; Mohty B; Harbi S; Devillier R; Chabannon C; Carlo-Stella C; Santoro A; Blaise D
    Bone Marrow Transplant; 2016 Mar; 51(3):462-5. PubMed ID: 26595078
    [No Abstract]   [Full Text] [Related]  

  • 5. A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation.
    Gaballa S; Palmisiano N; Alpdogan O; Carabasi M; Filicko-O'Hara J; Kasner M; Kraft WK; Leiby B; Martinez-Outschoorn U; O'Hara W; Pro B; Rudolph S; Sharma M; Wagner JL; Weiss M; Flomenberg N; Grosso D
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):141-8. PubMed ID: 26415558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of HLA-haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion based on an FBCA conditioning regimen for hematologic malignancies.
    Lin X; Lu ZG; Song CY; Huang YX; Guo KY; Deng L; Tu SF; He YZ; Xu JH; Long H; Wu BY
    Bone Marrow Transplant; 2015 Aug; 50(8):1092-7. PubMed ID: 25961770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant High-Dose Cyclophosphamide for Children and Adolescents with Hematologic Malignancies: An AIEOP-GITMO Retrospective Multicenter Study.
    Berger M; Lanino E; Cesaro S; Zecca M; Vassallo E; Faraci M; De Bortoli M; Barat V; Prete A; Fagioli F
    Biol Blood Marrow Transplant; 2016 May; 22(5):902-9. PubMed ID: 26860636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of low dose of fludarabine and cyclophosphamide combined with donor NK Cells as a non-myeloablative conditioning regimen for the haploidentical hematopoietic stem cell transplantation in mice].
    Yu JP; Cao S; Xin N; An XM; Qi J; Ren XB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1013-8. PubMed ID: 17956681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
    Cieri N; Greco R; Crucitti L; Morelli M; Giglio F; Levati G; Assanelli A; Carrabba MG; Bellio L; Milani R; Lorentino F; Stanghellini MT; De Freitas T; Marktel S; Bernardi M; Corti C; Vago L; Bonini C; Ciceri F; Peccatori J
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1506-14. PubMed ID: 26001696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.
    Bashey A; Zhang X; Sizemore CA; Manion K; Brown S; Holland HK; Morris LE; Solomon SR
    J Clin Oncol; 2013 Apr; 31(10):1310-6. PubMed ID: 23423745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
    Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conditioning regimen containing fludarabine instead of cyclophosphamide for haploidentical hematopoietic stem cell transplantation].
    Chen HR; He XP; Si YJ; Yang K; Hu B; DU ZL; Zhang XM; Zhang CC
    Zhonghua Xue Ye Xue Za Zhi; 2009 Aug; 30(8):514-8. PubMed ID: 19954636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis.
    Gorin NC; Labopin M; Piemontese S; Arcese W; Santarone S; Huang H; Meloni G; Ferrara F; Beelen D; Sanz M; Bacigalupo A; Ciceri F; Mailhol A; Nagler A; Mohty M;
    Haematologica; 2015 Apr; 100(4):558-64. PubMed ID: 25637051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections.
    Raj RV; Hari P; Pasquini M; Epperla N; D'Souza A; Fenske T; Shaw BE; Rizzo JD; Drobyski W; Hamadani M
    Bone Marrow Transplant; 2016 Dec; 51(12):1602-1604. PubMed ID: 27595288
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.
    Castagna L; Crocchiolo R; Furst S; Bramanti S; El Cheikh J; Sarina B; Granata A; Mauro E; Faucher C; Mohty B; Harbi S; Chabannon C; Carlo-Stella C; Santoro A; Blaise D
    Biol Blood Marrow Transplant; 2014 May; 20(5):724-9. PubMed ID: 24530426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halfway there: the past, present and future of haploidentical transplantation.
    Slade M; Fakhri B; Savani BN; Romee R
    Bone Marrow Transplant; 2017 Jan; 52(1):1-6. PubMed ID: 27454072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete resolution of severe ulcerative colitis after haploidentical hematopoietic stem cell transplantation followed by post-transplant high-dose cyclophosphamide.
    Unnikrishnan A; Glover SC; Norkina O; Wingard JR; Norkin M
    Bone Marrow Transplant; 2017 Aug; 52(8):1204-1205. PubMed ID: 28581471
    [No Abstract]   [Full Text] [Related]  

  • 18. Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome.
    Shin SH; Kim JH; Jeon YW; Yoon JH; Yahng SA; Lee SE; Choi YS; Kim DY; Lee JH; Lee S; Kim HJ; Min CK; Lee JW; Lee KH; Min WS; Kim YJ; Lee JH
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):342-9. PubMed ID: 25459640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide profiling in AML patients relapsing after allogeneic hematopoietic cell transplantation.
    Waterhouse M; Pfeifer D; Pantic M; Emmerich F; Bertz H; Finke J
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1450-1459.e1. PubMed ID: 21781950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT.
    Rubio MT; Savani BN; Labopin M; Piemontese S; Polge E; Ciceri F; Bacigalupo A; Arcese W; Koc Y; Beelen D; Gülbas Z; Wu D; Santarone S; Tischer J; Afanasyev B; Schmid C; Giebel S; Mohty M; Nagler A
    J Hematol Oncol; 2016 Mar; 9():25. PubMed ID: 26980295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.